“borderline significant”

A borderline significant association remained after controlling for differences in age category, sex, and site location (odds ratio [OR]: 1.70, 95% CI [1.00, 2.88], p = 0.05).

A borderline significant difference was observed in initial SOFA scores [8.0 (5.0–10.0) vs. 7.0 (5.0–9.0), p = 0.050], with higher scores among patients who required RRT.

Subgroup analysis on the effect of nitrate supplementation revealed a small, borderline significant effect in favour of chronic nitrate intervention (Hedges'g = 0.30, 95% CI -0.00 to 0.59, Z = 1.94, p = 0.05), but a trivial non-significant effect in favour of acute nitrate intervention (Hedges'g = 0.10, 95% CI -0.08 to 0.28, Z = 1.11, p = 0.27).

There was no significant difference between CD8 memory T-cell subsets ( Figure S3A ); however, for CD4 memory a significant lower level of Tem (CD45RA-CCR7-, p=0.02), and a borderline significant higher level of naïve (CD45RA+CCR7+, p=0.05) T-cells was detected in MACDZ compared to IGRA-HC ( Figure 2B ).

The CAT algorithm derived from the nurse focus group was a borderline significant predictor of hospitalization risk (odds ratio (OR): 1.07; 95% confidence interval (CI): 1.00–1.14; p = 0.050) in a model that also included hospitalization frequency in the previous year (OR: 3.98; 95% CI: 1.30–12.16; p = 0.016) and anticholinergic risk score (OR: 3.08; 95% CI: 0.87–10.89; p = 0.081).

A borderline significant correlation was present when exciting with 440 nm (r = 0.57, p = 0.05) and 750 nm (r = 0.55, p = 0.06).

A borderline significant association was found with those who have shorter incarcerated period and clustering (21 vs. 14 days; OR = 1.01 [95% CI: 1–1.01], P = 0.05; Table 3 ) while receiving income assistance (e.g., disability check, military, TANF, AFDC) (29% vs. 16%; OR = 0.477 [95% CI: 0.29–0.80], P = 0.005; Table 3 ) decreased the odds of being in a cluster.

A borderline significant effect was also observed on the somatic sensory item ( p =0.05).

The test for between study heterogeneity was borderline significant ( P =.05, I‐squared=75.1%).

As compared to 300 m altitude, training at 1,900 m showed borderline significant differences in the pre-post mean reduction rates of triglyceride (p = 0.050) and leptin levels (p = 0.093).

ITT Eradication Rates Meta‐analysis of 8 trials (2502 patients: 1318 tailored; 1184 concomitant) showed a borderline significant difference favoring tailored therapy (RR = 1.05; 95% CI: 1.00–1.10; p = 0.05; I 2 = 58%) (Figure 2 ).

For the other worst-response-associated lipids, the correlations were positive for 10–15 of the 15 medications, with 41% percent of lipids showing significant values and 45% borderline significant values (binomial test p < 0.05 and p = 0.059, respectively; Figure S4 ).

Moreover, in a prospective randomized, double-blind, placebo-controlled trial enrolling 106 patients with both NAFLD and T2DM who were assigned to receive empagliflozin 10 mg ( n = 35), pioglitazone 30 mg ( n = 34), or placebo ( n = 37) for 24 weeks, only a borderline significant decrease in CAP score was observed with empagliflozin compared with placebo (−29.6 dB/m (−39.5 to −19.6) vs. −16.4 dB/m (−25.0 to −7.8), respectively; p = 0.05) [ 39 ].

The results also displayed a borderline significant difference across the genetic risk scores for body fat mass (p = 0.05), percentage of body fat (p = 0.05), serum HDL concentration (p = 0.08), and CRP (p = 0.06).

In the parsimonious model, HPV18 positivity remained borderline significant (adjusted OR = 4.17, 95% CI: 1.00–16.97; p = 0.050.

None of these lipids was significantly heritable, with maximum heritability of 0.39, though one TG (TG18:1_17:1_22:6) was borderline significant (p=0.05 for h 2 ), with a maximum of two significant gene expression associations (for TG18:1_17:1_22:6 and TG18:1_20:4_22:6).

While mortality between the cohorts remained unchanged, the combined stroke/TIA risk converged with the passage of time: at 2 years, the risk was borderline significant (11.2% vs. 6.5%, p = 0.05) [ 16 ], and at 5 years the risk was equivalent between the groups (15.9% vs. 14.7%, p = 0.35) [ 17 ].

From the included studies, the latter was the only intervention that observed a borderline significant increase in total body aBMD ( p = 0.05).

This study found that patients with CeD, younger-onset diabetes, MS, asthma, and SLE were at higher risk of ALS, and the rate ratio for UC was borderline significant ( P = 0.05), and no significant difference was found for RA, psoriasis and CD.

After adjustment, the associations between FTO and baseline BMI remained borderline significant ( p = 0.050).

Subjective norms were borderline significant ( p = .05).

Semen analysis showed a borderline significant difference between the group with triple-biopsy where sperm count was lower than it in the control group (14.5 mill/mL vs. 17.5 mill/mL, p = 0.05).

The IgAN237 score showed a significant correlation with proteinuria (ρ = 0.181, P = 0.011) and a borderline significant correlation with baseline eGFR (ρ = −0.136, P = 0.05) ( Figure 3A ).

The difference in mean triglyceride level in the placebo group was not significant after the intervention, although there was a borderline significant difference in the intervention group (p=0.05); nevertheless, the changes in mean triglyceride level between the two groups did not indicate a significant difference.

The liking for other vegetables not targeted in the study remained unchanged, except for a borderline significant drop in liking for the nontargeted vegetable celery ( P = .05).